شركة رقمي
نقل من موقع 
Nov 5 (Reuters) - Pfizer Inc (PFE.N) and United Nations-backed Medicines Patent Pool (MPP) are in advanced talks on a licensing agreement that would allow qualified third parties to manufacture and supply the U.S. drugmaker"s oral antiviral pill candidate, pending regulatory nod, the MPP told Reuters.
مشاركة :
